MedPath

Effect of probiotics on the incidence of necrotizing enterocolitis in preterm

Phase 2
Conditions
ecrotizing enterocolitisPreterm neonatesNeonatal sepsis
Probiotics
Necrotizing enterocolitis
Preterm
Neonatal sepsis
Registration Number
TCTR20200101001
Lead Sponsor
Faculty of Medicine Siriraj Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
388
Inclusion Criteria

- Preterm neonates with postmenstrual age less than or equal 33 wk and birth weight less than or equal 1500 g
- Admitted to NICU or intermediate care ward
- Able to tolerate feeding at least 1 ml/feed every 3 hours for 8 feeds
- Has not received antibiotic for at least 24 hr before enrollment
- Parental consent
- Physician agrees for the patient to enroll

Exclusion Criteria

- Known or suspected immunodeficiency
- Inborn error of metabolism
- Congenital heart disease except PDA, ASD and VSD
- Congenital anomaly of GI tract
- Previous NEC stage 2 or 3
- Patients having active infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EC stage 2 or above From enrollment to hospital discharge Clinical diagnosis, abdominal Xray
Secondary Outcome Measures
NameTimeMethod
Incidence of neonatal sepsis Within 30 days and 60 days after enrollment or until hospital discharge Clinical diagnosis and blood culture,Hospital mortality rate - -,Time to full enteral feeding - Number of days from enrollment to full enteral feeding (at least 120 ml/kg/day),Incidence of infection due to probiotic strain From enrollment to hospital discharge Clinical diagnosis and culture results
© Copyright 2025. All Rights Reserved by MedPath